基于T细胞的新型仿制抗原受体免疫疗法:三阴性乳腺癌的前景
Peizhen Geng1, Yuhua Chi2, Yuan Yuan1
1School of Clinical Medicine, Affiliated Hospital of Weifang Medical University, Weifang Medical University, Weifang, Shandong, China.
Frontiers in cell and developmental biology
|July 17, 2023
概括
化学抗原受体T细胞 (CAR-T) 疗法对侵袭性三阴性乳腺癌 (TNBC) 是有前途的. 研究探讨了CAR-T的目标和策略,以克服治疗这种具有挑战性的固体瘤的挑战.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种缺乏ER,PR和HER2表达的攻击性亚型.
- 目前的疗法对TNBC的疗效有限,需要新的治疗方法.
- 化学抗原受体T细胞 (CAR-T) 治疗在血液癌症中是有效的,但对于像TNBC这样的固体瘤来说是不理想的.
研究的目的:
- 审查TNBC的CAR-T治疗应用程序.
- 为了确定TNBC中潜在的CAR-T治疗点.
- 探索增强固体瘤中CAR-T疗效的策略.
主要方法:
- 对TNBC的CAR-T进行的临床前和临床研究的文献综述.
- 分析已识别的CAR-T目标和局限性.
- 检查克服CAR-T治疗障碍的策略.
主要成果:
- 研究中已经确定了TNBC的几个潜在的CAR-T目标.
- 应用CAR-T疗法对固体瘤,包括TNBC,存在重大挑战.
- 目前正在制定各种战略,以提高CAR-T对TNBC的有效性.
结论:
- 卡特-T免疫疗法代表了TNBC治疗的有希望的途径.
- 克服当前的局限性对于在TNBC中成功应用CAR-T至关重要.
- 在CAR-T策略的进一步进展可能会改善TNBC的患者预后.
相关概念视频
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K